Muller TD, Finan B, Bloom SR, D'Alessio D, Drucker DJ, Flatt PR, Fritsche A, Gribble F, Grill HJ, Habener JF, Holst JJ, Langhans W, Meier JJ, Nauck MA, Perez-Tilve D, Pocai A, Reimann F, Sandoval DA, Schwartz TW, Seeley RJ, Stemmer K, Tang-Christensen M, Woods SC, DiMarchi RD, Tschop MH
Colberg SR, Sigal RJ, Yardley JE, et Physical activity/exercise and diabetes: a position statement of the American Diabetes Association
This med is amazing
Analyses of endpoints for the trial product estimand were not adjusted for multiplicity
Understanding Gastroparesis: A Rare but Serious Concern In very rare cases, GLP-1 medications can cause a condition called gastroparesis
ICP was significantly lower in the exenatide group compared to placebo after 12 weeks (exenatide 21.4 (4.0) cmCSF, placebo 26.0 (4.4) cmCSF p = 0.058)